Generic Timolol Maleate Ophthalmic Gel-Forming Solution from Germany
Gel-forming ophthalmic solution with timolol maleate for once-daily glaucoma treatment, in retail multi-dose bottles. It qualifies for HTS 3004.90.92.72 as an eye-affecting medicament in measured doses containing timolol maleate, distinct from standard drops. The gel matrix provides prolonged release for therapeutic efficacy.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Ensure gel formulation stability testing reports are available for CBP review during ophthalmic import clearance
• Comply with USP standards for sterility and include batch certificates to expedite FDA admission
• Watch for misclassification pitfalls by specifying 'measured dose retail packing' in entry documentation